Fifth Third Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fifth Third Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$480K	Sell	1,994 -2	-0.1%	-$438	0.01%	506
2026 Q1	$377K	Buy	1,996 +85	+4%	+$14.9K	0.01%	521
2025 Q4	$325K	Sell	1,911 -40	-2%	-$6.13K	0.01%	551
2025 Q3	$257K	Buy	1,951 +44	+2%	+$5.28K	0.01%	621
2025 Q2	$202K	Buy	1,907 +5	+0.3%	+$543	0.01%	722
2025 Q1	$236K	Buy	1,902 +6	+0.3%	+$783	0.01%	599
2024 Q4	$233K	Sell	1,896 -33	-2%	-$3.89K	0.01%	618
2024 Q3	$215K	Sell	1,929 -5	-0.3%	-$548	0.01%	627
2024 Q2	$206K	Buy	+1,934	New	+$213K	0.02%	591

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Fifth Third Wealth Advisors's JAZZ Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.1% in Q2 2026, selling an estimated $438 and leaving 1,994 shares worth $480K. The position accounts for 0.01% of the portfolio, ranked #506.

Fifth Third Wealth Advisors first reported a position in JAZZ in Q2 2024 and has held it in 9 quarters since. 87 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Fifth Third Wealth Advisors held 1,994 shares of Jazz Pharmaceuticals worth $480K as of Q2 2026.
Fifth Third Wealth Advisors sold 2 Jazz Pharmaceuticals shares in Q2 2026, an estimated $438.
Jazz Pharmaceuticals made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #506 holding.
Fifth Third Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
87 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.